Stocks · Healthcare · Medical - Healthcare Information Services
Omnicell, Inc. OMCL
$33.60 +0.48% Close, Oct 2, 2026 · NASDAQ · Market cap $1.53B
High qualityInexpensive vs sectorLow risk
Next earnings report: Oct 29, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Diluted EPS over the last four quarters was $0.84, up 69.0% year over year.
- At 39.8× trailing earnings, the shares trade at the lowest P/E of the company's past five years.
- The stock is in a downtrend: below its 200-day average, with the 50-day average below the 200-day.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 49%
- EPS growth (TTM, YoY)Top 19%
- FCF growth (TTM, YoY)Top 35%
- Revenue growth, 3-year CAGRBottom 18%
- Revenue growth accelerationTop 39%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 28%
- Gross marginBottom 30%
- Operating marginTop 35%
- Cash conversion (OCF / net income)Top 10%
- Accruals (lower is better)Top 47%
- Net debt / EBITDA (lower is better)Top 20%
- Interest coverTop 11%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 21%
- Free-cash-flow yieldTop 8%
- EBITDA / enterprise valueTop 15%
- Sales / enterprise valueTop 11%
- P/E vs own 5-year history (lower is better)Top 6%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 46%
- 6-month returnBottom 42%
- 1-year return vs S&P 500Bottom 49%
- Distance from 52-week highBottom 41%
- Trend checklist (0–4)Bottom 38%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 12%
- Consecutive EPS beatsTop 35%
- Share of analysts rating BuyBottom 14%
- Upside to consensus price targetTop 47%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 29%
- Maximum drawdown, 3 yearsTop 27%
- Beta vs S&P 500 (lower is better)Top 37%
- Net debt / EBITDA (lower is better)Top 20%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 7.9% | 8.5% | ↑ |
| EPS growth (YoY) | -3.5% | 69.0% | ↑ |
| Gross margin | 43.9% | 44.8% | ↑ |
| Operating margin | 1.5% | 4.7% | ↑ |
| FCF margin | 8.9% | 11.3% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 8.5% | 7.9% | ↑ | Bottom 49% |
| EPS growth (TTM, YoY) | 69.0% | -3.5% | ↑ | Top 19% |
| Gross margin | 44.8% | 43.9% | ↑ | Bottom 30% |
| Operating margin | 4.7% | 1.5% | ↑ | Top 35% |
| Net margin | 3.1% | 2.0% | ↑ | — |
| Free-cash-flow margin | 11.3% | 8.9% | ↑ | — |
| Return on invested capital | 2.4% | — | Top 28% | |
| Revenue growth, 3-year CAGR | -2.9% | — | Bottom 18% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 3.00×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -7.2%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 2.6%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -10.9 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- -0.87×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 14.9×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 3.52%
- Shareholder yield
- 3.52%
- Share count change, 1 year
- -1.8%
- Share count change, 3-year CAGR
- +0.5%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 5, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 2
- Beats in the last 8 reports
- 7 of 8
- Average EPS surprise, last 4
- +48.6%
- Average 2-day reaction, last 8
- +2.2%
- Positive 20 days after report
- 5 of 8
Analysts
- Consensus price target
- $56.67
- Target vs current price
- +68.7%
- Analysts with a rating
- 19
- Share rating Buy or Strong Buy
- 47%
- Consensus rating
- Hold
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 30, 2026 | +101.1% | -10.4% | -10.2% | -19.2% | — |
| Apr 28, 2026 | +66.7% | +20.9% | +15.4% | +17.2% | +5.9% |
| Feb 5, 2026 | -14.9% | -16.3% | -19.0% | -9.5% | -8.3% |
| Oct 30, 2025 | +41.7% | +13.6% | +20.9% | +24.0% | +69.0% |
| Jul 31, 2025 | +45.2% | +4.4% | +4.7% | +11.9% | +4.0% |
| May 6, 2025 | +62.5% | -15.8% | -9.9% | +1.7% | +1.7% |
| Feb 6, 2025 | +5.3% | -11.2% | -8.8% | -16.1% | -29.8% |
| Oct 30, 2024 | +36.6% | +32.2% | +24.1% | +13.3% | +11.9% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 30, 2026 | $0.94 | $0.47 | +101.1% | $312.2M |
| Apr 28, 2026 | $0.55 | $0.33 | +66.7% | $309.9M |
| Feb 5, 2026 | $0.40 | $0.47 | -14.9% | $314.0M |
| Oct 30, 2025 | $0.51 | $0.36 | +41.7% | $310.6M |
| Jul 31, 2025 | $0.45 | $0.31 | +45.2% | $290.6M |
| May 6, 2025 | $0.26 | $0.16 | +62.5% | $269.7M |
| Feb 6, 2025 | $0.60 | $0.57 | +5.3% | $306.9M |
| Oct 30, 2024 | $0.56 | $0.41 | +36.6% | $282.4M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 39.8× | 83.3× | 0th | Top 21% |
| P/E (forward) | 14.8× | — | — | — |
| EV / EBITDA | 13.5× | — | — | Top 15% |
| EV / Sales | 1.15× | — | — | Top 11% |
| Free-cash-flow yield | 9.25% | — | — | Top 8% |
| Earnings yield | 2.51% | — | — | Top 21% |
P/E over the past five years
Range 44.0× – 141.9× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +12.1%
- Earnings per share growth (TTM)
- +69.0%
- Change in P/E multiple
- -17.7%
Most of the move came from earnings growth.
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -10.5%
- 200-day average slope (20 days)
- -1.4%
- Distance from 50-day average
- -4.7%
- Distance from 200-day average
- -16.3%
- RSI (14)
- 46.7
- Relative volume
- 0.63×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 44.8%
- Volatility vs own 5-year history
- 49th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.90
- Correlation with S&P 500
- 0.29
- Current drawdown from 1-year high
- -34.6%
- Maximum drawdown, 3 years
- -53.6%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Nov 23, 2021 | May 7, 2025 | -86.6% | 865 days | Not yet recovered |
| Apr 30, 2021 | May 10, 2021 | -10.4% | 6 days | 27 days (Jun 17, 2021) |
| Mar 17, 2021 | Mar 30, 2021 | -10.3% | 9 days | 22 days (Apr 30, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $1.53B
- P/E (TTM)
- 39.8
- EPS, diluted (TTM)
- $0.84
- Revenue (TTM)
- $1.25B
- 52-week range
- $29.06 – $55.00
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $1.13B | $1.30B | $1.15B | $1.11B | $1.18B |
| Gross profit | $554.7M | $589.0M | $499.9M | $471.0M | $508.0M |
| Operating income | $89.5M | -$2.3M | -$19.3M | $337,000 | $11.7M |
| Net income | $77.8M | $5.6M | -$20.4M | $12.5M | $2.1M |
| EPS (diluted) | $1.62 | $0.12 | -$0.45 | $0.27 | $0.04 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $282.4M | $306.9M | $269.7M | $290.6M | $310.6M | $314.0M | $309.9M | $312.2M |
| Net income | $8.6M | $15.8M | -$7.0M | $5.6M | $5.5M | -$2.0M | $11.4M | $24.3M |
| EPS (diluted) | $0.19 | $0.34 | -$0.15 | $0.12 | $0.12 | -$0.05 | $0.25 | $0.52 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $231.8M | $77.8M | $181.1M | $187.7M | $127.3M |
| Capital expenditure | -$29.0M | -$60.7M | -$41.5M | -$36.5M | -$40.4M |
| Free cash flow | $202.8M | $17.0M | $139.6M | $151.3M | $86.9M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | -$16.3M | -$12.0M | $23.2M | $38.6M | -$60.7M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $307.0M
- Total assets
- $2.00B
- Total liabilities
- $707.3M
- Total debt
- $200.0M
- Net debt
- -$92.2M
- Shareholders’ equity
- $1.29B
As of Jun 30, 2026 (filed Aug 5, 2026).
Short interest
- Shares sold short
- 3,291,305
- Days to cover
- 5.48
- Change vs previous report
- -0.1%
FINRA short interest, settlement date Sep 15, 2026.